Study S000326

Epicardial Cardiac Fat Comparative Trial

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07297589
Acronym: EPIC-CT
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: SINGLE
Status: RECRUITING
Enrollment: 136
Start: 2025-12-30
Primary completion: 2027-01
Lead sponsor: Instituto Mexicano del Seguro Social
Conditions: STEMI - ST Elevation Myocardial Infarction; Epicardial Fat
Interventions: DRUG:Dapagliflozin 10 MG Oral Tablet; DRUG:Semaglutide (Rybelsus®)
Results posted: FALSE

Registered primary outcomes

Epicardial fat [12 months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.